You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hormone Receptor Negative Breast Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +5 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jul 14, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma

Not yet recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +3 more
  • Accelerated Partial Breast Irradiation
  • Duarte, California
    City of Hope Medical Center
Aug 18, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +7 more
  • Portland, Oregon
    SWOG
Sep 27, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma Trial (other, procedure, behavioral)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Electronic Health Record Review
  • +6 more
  • (no location specified)
Oct 27, 2023

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Bintrafusp Alfa
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 2, 2022

    Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

    Terminated
    • Estrogen Receptor Positive
    • +16 more
    • Biopsy of Breast
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 22, 2022

    Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer Trial in

    Recruiting
    • Hormone Receptor Positive Breast Carcinoma
    • +2 more
    • Chicago, Illinois
    • +2 more
    Jul 1, 2022

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

    Active, not recruiting
    • Estrogen Receptor-positive Breast Cancer
    • +5 more
    • PI3K inhibitor BYL719
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Oct 14, 2022

    Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

    Active, not recruiting
    • Estrogen Receptor Positive
    • +3 more
    • Radiation Therapy
    • Therapeutic Conventional Surgery
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 14, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • (no location specified)
    Nov 8, 2022

    Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

    Not yet recruiting
    • Breast Cancer
    • +8 more
    • (no location specified)
    Feb 9, 2023

    Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

    Not yet recruiting
    • Breast Cancer Invasive
    • +3 more
    • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
    • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Nov 17, 2023

    Blood and Tumor Samples From Advanced or Metastatic Estrogen

    Active, not recruiting
    • Advanced Breast Carcinoma
    • +8 more
    • Biopsy
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 3, 2023

    Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Washington, District of Columbia
    • +4 more
    Jan 31, 2023

    Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)

    Active, not recruiting
    • Carcinoma, Ductal, Breast
    • +2 more
    • Sofia, Bulgaria
    • +7 more
    Aug 1, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +3 more
    • Best Practice
    • +3 more
    • Atlanta, Georgia
    • +3 more
    Aug 2, 2022

    HER2-positive Breast Cancer, HER2 Low, SYD-985 Trial in Aurora (Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

    Recruiting
    • HER2-positive Breast Cancer
    • +26 more
    • Vic-trastuzumab duocarmazine (SYD985) + paclitaxel
    • Aurora, Colorado
      University of Colorado Cancer Center
    Oct 22, 2021